Related Experiment Video
Updated: Jun 23, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Antiretroviral therapy in developing countries: pharmacologic considerations
Mohammed Lamorde1, Pauline Byakika-Kibwika, Concepta Merry
1Infectious Diseases Institute, Faculty of Medicine, Makerere University, Kampala, Uganda.
Current Opinion in HIV and AIDS
|April 18, 2009
Summary
Genetic variations affect antiretroviral drug levels, leading to inadequate concentrations in children, particularly in developing nations. This highlights the need for better access to HIV/AIDS treatment and further research.
Area of Science:
- Clinical Pharmacology
- Pharmacogenomics
- Global Health
Background:
- Antiretroviral drugs are crucial for HIV/AIDS management.
- Understanding drug pharmacokinetics is essential for effective treatment.
- Developing countries face unique challenges in HIV/AIDS care.
Purpose of the Study:
- To review recent clinical pharmacology studies of antiretroviral drugs.
- To highlight findings relevant to HIV/AIDS treatment in developing countries.
- To address pharmacokinetic variability and its clinical implications.
Main Methods:
- Literature review of recent studies.
- Analysis of pharmacogenetic factors influencing drug metabolism.
- Examination of antiretroviral concentrations in pediatric populations.
Main Results:
- Genetic polymorphisms in drug-metabolizing enzymes significantly impact antiretroviral pharmacokinetics.
- Subtherapeutic antiretroviral concentrations are frequently observed in children.
- A study in African children showed 40% receiving efavirenz had inadequate drug levels at standard doses.
Conclusions:
- Pharmacokinetic differences in antiretroviral drugs necessitate tailored approaches.
- Poverty exacerbates challenges in HIV/AIDS treatment and prevention.
- Improved access to care, socioeconomic support, and targeted research are critical for effective HIV/AIDS management in resource-limited settings.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...